NEW YORK, Nov. 2, 2017 /PRNewswire/ -- PUMPING SYSTEM: THE HEART OF THE MICROFLUIDIC DEVICEThe worldwide market forpumps for microfluidic devices is growing quickly. Pumps are the cornerstone of microfluidic systems. They are the key component that allows the motion of fluids in an accurate and reliable manner through a device's reservoirs, chambers and microchannels.
Read the full report: https://www.reportlinker.com/p05168528
Mechanical pumps include electrostatic, electromagnetic, piezoelectric, thermopneumatic, shape memory alloy, bimetallic and ion polymer conducting film technology. Non-mechanical pumps include magneto-hydrodynamic, electro-hydrodynamic, electroosmotic, electrowetting, electrochemical and bubble-type. This patent landscape report analyzes IP activity for each technology. The analysis of the technical issues addressed by patents related to pumps for microfluidic devices supports what we observe in the market. Mechanical pumps dominate, but new applicants, in particular from China, could accelerate the development of non-mechanical pumps for microfluidics.IDENTIFY KEY PLAYERSThe report provides a ranking and analysis of the relative strength of the top patent holders derived from their portfolio size, patent citation networks, countries of patent filings and current legal status of patents. Through this in depth analysis, we have identified 20+ major players. Each of those players is profiled in this report. The profiles include a detailed portfolio analysis with patent activities, key patents, impact of the company's portfolio, granted patents near expiration and IP strategies. The IP landscape for pumps for microfluidic devices is driven by American applicants. But a few European applicants also have interesting IP assets.IDENTIFY KEY TECHNOLOGIESThis IP landscape for pumps for microfluidic devices reveals the key patents in this domain, as well as the pump technology they are related to. Two technologies were a particular focus for patent applicants: piezoelectric and electroosmotic technologies. However, recently, Chinese patent applicants started to show a strong interest for electrohydrodynamic pumps.KEY PLAYERS: IP PROFILE AND KEY PATENTSThe patent landscape related to pumps for microfluidic devices provides a detailed profile for each key player, including portfolio size, filing countries, leadership assessment as well as a selection of key patents. This analysis reveals that most of the key players are focused in the same mechanical technology: piezoelectric technology. However several key players show more interest in non-mechanical pumps, including Intel, Stanford, and MIT. This report also includes an Excel database containing all of the analyzed patents. The database allows for multi-criteria searches and includes patent publication numbers, hyperlinks to the original documents, priority dates, titles, abstracts, patent assignees and legal status for each member of the patent family.
COMPANIES AND ACADEMICS CITED IN THE REPORT (NON-EXHAUSTIVE)Agilent Technologies, Baxter International, Bigfoot Biomedical, Bosch, Caltech, Debiotech, Epson, Fraunhofer, Hitachi, Honeywell, Intel, ITRI, Konica Minolta, Medtronic, MIT, Panasonic, Roche, Seiko Instruments, Stanford University, University of California, Waters Corporation, etc.Read the full report: https://www.reportlinker.com/p05168528 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com
__________________________ Contact Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/pumps-for-microfluidic-devices-patent-landscape-300548954.html
Subscribe to our Free Newsletters!
Bladder neck incision is a surgical procedure where cuts are made in the neck of the urinary ...
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...View All